The team is working towards the development of more specific and stable anti venom for effectively controlling the burden of snakebite morbidity, disability and mortality, globally. To upgrade product safety, efficacy and clinical potency of antivenom, we  also focus on camelid based antiserum development .

The team is working towards the production of bio-fuel from various feed stocks in a simple, inexpensive and environmental friendly way. 

The team is working on  developing an efficient mobile app for explicit snake identification based on artificial intelligence. This app will combine AI with the expertise from a network of proficient herpetologists to identify photos of snakes, particularly supporting victims and clinicians when urgent and reliable snake identification is needed.

We have experienced R&D team working on venom proteomics and venom gland transcriptomics platform for venom based drug discovery.